A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

NCT07232524 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Solid Tumor

Interventions

DRUG: BL-M24D1

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]